The Gumpii Apothecary
DMSO 99.9% Pharma Grade | Low Odour Dimethyl Sulfoxide
DMSO 99.9% Pharma Grade | Low Odour Dimethyl Sulfoxide
Couldn't load pickup availability
What is DMSO?
DMSO (Dimethyl Sulfoxide) is a naturally derived organosulfur compound that has been the subject of extensive scientific research — from its role in targeted topical application and inflammation to free radical scavenging, transdermal delivery, and neuroprotection research.
Our DMSO starts as 99.9% pharmaceutical grade — the purest available. We dilute it to 80% as a deliberate safety measure, reducing the risk of accidental misuse while maintaining its integrity and effectiveness as a topical solution.
Why Low Odour Matters
Standard DMSO is notorious for its strong garlic-like odour — a significant barrier to everyday use. Our pharmaceutical-grade, low-odour formulation delivers the same properties without the social inconvenience, making it suitable for regular topical application at home or work.
How to Use
Apply topically to clean, dry skin over the affected area. DMSO is a powerful carrier — ensure the skin and any applicator are thoroughly clean before use, as it will carry whatever is on the skin's surface into the body.
- This product is supplied at 80%. If you wish to dilute further, start at 70% (30ml DMSO / 20ml pure water) and increase gradually as tolerated. Do not use undiluted pharmaceutical-grade DMSO (99.9%) without professional guidance.
- Store in glass
- Monitor for skin irritation, especially in early use
- Use caution if taking blood thinners or steroids — DMSO amplifies absorption of other substances
- Pregnant women and those with liver disease should consult a healthcare practitioner before use
For external use only. Always consult a qualified healthcare practitioner before commencing use, particularly if combining with other topical medications or substances.
Research Areas
The following summarises areas where DMSO has been studied. These are research findings about DMSO as a compound — they are not claims about this product's ability to treat, prevent, diagnose or cure any condition.
- Anti-Inflammatory Research: Studies have investigated DMSO's effect on pro-inflammatory cytokines (TNF-α, IL-1, IL-6) and COX-2 enzyme activity — the same pathway targeted by many pharmaceutical pain medications.
- Topical Application: Research has explored DMSO's use when applied topically to areas of muscle and joint discomfort.
- Transdermal Carrier Research: DMSO has been studied as a transdermal carrier, with research exploring how it may assist other topically applied compounds to penetrate the skin more effectively.
- Free Radical Research: Studies have investigated DMSO's interaction with reactive oxygen species (ROS) including hydroxyl radicals and superoxide anions.
- Neuroprotection Research (Preclinical): Laboratory and animal research has explored DMSO's potential role in reducing brain oedema and excitotoxicity. Early-stage preclinical research has investigated its potential in neurodegeneration.
- Oncology Research (In Vitro): Laboratory studies have investigated DMSO's effect on cancer cell lines in controlled cell culture settings.
- Cellular Stress Response: Research has explored how DMSO at low to moderate levels may activate cellular stress response programs.
- Wound Healing Research: Some studies have explored DMSO's potential role in tissue repair in the context of oxidative damage reduction.
- Cardiovascular Research: Research has explored DMSO's potential role in cardiovascular contexts, including its properties as a free radical scavenger and anti-inflammatory agent.
How DMSO's Anti-Inflammatory Mechanisms Have Been Studied
Research has investigated several mechanisms by which DMSO may interact with inflammatory pathways:
- Inhibition of pro-inflammatory cytokines — TNF-α, IL-1, and IL-6 — has been studied in laboratory settings
- COX-2 enzyme activity suppression, reducing prostaglandin production, has been explored in research contexts
- Interaction with free radicals and reactive oxygen species (ROS) has been investigated in laboratory studies
- Topical penetration to localised areas has been studied in the context of transdermal delivery research
Research interest has included inflammatory conditions such as rheumatoid arthritis, osteoarthritis, and neuroinflammation. Consult your healthcare practitioner for guidance specific to your situation.
Neuroprotection — Preclinical Research
- Brain oedema research: DMSO's osmotic properties have been studied in the context of intracranial pressure and cerebral blood flow in preclinical settings.
- Excitotoxicity research: Studies have explored DMSO's potential modulation of glutamate release and NMDA receptor activity in laboratory models.
- Neurodegeneration research (preclinical): In a mouse model, low-dose DMSO was investigated in relation to visual function in mice showing early signs of impairment. Researchers observed normalisation of the ELM-RPE retinal layer, suggesting potential effects on oxidative stress pathways in the central nervous system. These are preclinical findings only.
- Carrier research: DMSO's potential to enhance delivery of other compounds across biological membranes has been studied in laboratory settings.
Note: These are preclinical studies only. Large-scale human clinical trials are ongoing. DMSO should be used under qualified healthcare supervision.
DMSO as a Cellular Stressor — Research Context
At low to moderate levels, research has explored how DMSO may activate the cellular Environmental Stress Response (ESR) program — a biological alarm system triggered by mild stressors. Research on yeast cells found that short-term exposure to moderate DMSO levels triggered stress response genes without significantly damaging cell membranes or metabolic activity. This research context helps explain DMSO's use in cryopreservation and as a subject of study in radiation damage protection.
Oncology Research — In Vitro Studies
Laboratory studies have investigated DMSO's effects on cancer cell lines in controlled cell culture settings. Researchers studied its impact on leukemia cells (MV4-11 and TF-1a) and epithelial cancer cells (Hep-G2 liver cancer and MCF7 breast cancer cells):
- DMSO was observed to inhibit cell growth in tested cancer cell lines in laboratory conditions
- At 10% DMSO, growth inhibition reached up to 69% in some cell lines after 72 hours in cell culture
- 5% DMSO increased cell death rates from ~2–3% to 15–19% in leukemia cells after 48 hours in laboratory conditions
- Cancer cells showed nuclear fragmentation — a hallmark of apoptosis (programmed cell death) — in these in vitro studies
- DMSO decreased levels of CDK2 and cyclin A — proteins that regulate cell division — in laboratory cell culture settings
- DNA fragmentation and caspase 3 activation were observed in laboratory conditions, consistent with apoptosis via the extrinsic pathway
These are in vitro (cell culture) findings only and do not constitute evidence that this product prevents, treats or cures cancer. Consult your oncologist or healthcare practitioner.
Traditional & Clinical Research Context
- Arthritis — traditionally used topically; some research has explored its effect on joint discomfort
- Musculoskeletal Use — traditionally applied topically to areas of muscle and joint discomfort including sprains, strains, and tendonitis
- Interstitial Cystitis — DMSO has FDA approval in the US for this specific clinical application when administered by a healthcare professional in a clinical setting. This product is for topical external use only and is not an equivalent to that clinical treatment.
- Clinical Research Context — DMSO has been studied in clinical settings in relation to chemotherapy drug extravasation management
- Neuroinflammatory Research — emerging preclinical research is exploring DMSO's role in neuroinflammation
- Antibacterial Research: Laboratory studies have investigated DMSO's antibacterial properties against various bacterial strains
Research & References
The following sources informed this product page. Claims on this page reflect research findings about DMSO as a compound and are not product-specific therapeutic claims.
- National Library of Medicine, PubChem — Dimethyl Sulfoxide
- Stanley W. Jacob MD — DMSO Research Overview, DMSO.org
- PubMed — PMID 36459193 (2022)
- Dr Mark Sircus — DMSO and Heart Disease (Cardiovascular Research Overview)
- Lockie LM, Norcross BM. A Clinical Study on the Effects of DMSO in 103 Patients with Acute and Chronic Musculoskeletal Injuries and Inflammations. Annals of the New York Academy of Sciences.
